# Effect of Tigulixostat on the Pharmacokinetics of Theophylline

> **NCT06189404** · PHASE1 · COMPLETED · sponsor: **LG Chem** · enrollment: 24 (actual)

## Conditions studied

- Gout
- Hyperuricemia

## Interventions

- **DRUG:** Tigulixostat
- **DRUG:** Theophylline

## Key facts

- **NCT ID:** NCT06189404
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-31
- **Primary completion:** 2023-11-13
- **Final completion:** 2023-11-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06189404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06189404, "Effect of Tigulixostat on the Pharmacokinetics of Theophylline". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06189404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*